Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 663, pseudogene (RNU6-663P) is a pseudogene of the U6 small nuclear RNA. It does not encode a functional product and is not considered a protein, enzyme, receptor, or other conventional therapeutic target. While the functional U6 small nuclear RNA is a crucial non-coding RNA involved in pre-mRNA splicing as part of the spliceosome, pseudogenes such as RNU6-663P are generally transcriptionally inactive, lack biological function, and are not implicated in human disease or as drug targets. Their sequence is typically a remnant of gene duplication or retrotransposition events during evolution, and they may show sequence homology to the functional U6 snRNA but do not participate in spliceosome activity. This is a nonfunctional genomic DNA sequence. It is not a target for therapeutics or drug development, nor is it relevant for biomarker or therapeutic safety discussions. If a real therapeutic target was intended, the query likely needs correction to use the canonical, functional U6 snRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 663, pseudogene (RNU6-663P).